Business · 28/09/2004
FDA Announces Draft Guidance on Combination Product User Fees
The Food and Drug Administration (FDA) has released a draft document outlining user fees for marketing applications of combination products, aiming to facilitate innovation in the pharmaceutical industry.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →